Market Access
Biotech leaders: ‘They're shoving this industry into the arm...
At the Biotech Showcase during JPM Week, biotech leaders expressed frustration at the US's lack of concern about Chinese biotech progress.
News
Fears US drug pricing deal will weigh heavy on the NHS
The UK confirms that the cost of the drug pricing deal with the US, initially around £1bn over three years, will be borne by the health department.
News
FDA knocks back AstraZeneca's self-injected lupus drug
FDA has delivered a setback to AstraZeneca by rebuffing its new formulation of lupus therapy Saphnelo, which was approved in Europe last year.
News
FDA knocks back Pharming's bid for wider Joenja use
The FDA has turned down Pharming's bid to broaden the label of Joenja for rare immunodeficiency disorder APDS so it can be used in younger patients.
News
FDA launches pilot programme to boost US manufacturing
The FDA has started accepting requests to participate in its PreCheck pilot programme, promising rapid reviews of new manufacturing facilities.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
